Stocker, N., Gaugler, B., Ricard, L., de Vassoigne, F., Marjanovic, Z., Mohty, M., & Malard, F. (2020). Daratumumab prevents programmed death ligand‐1 expression on antigen‐presenting cells in de novo multiple myeloma. Cancer Med.
Chicago ZitierstilStocker, Nicolas, Béatrice Gaugler, Laure Ricard, Frédéric de Vassoigne, Zora Marjanovic, Mohamad Mohty, und Florent Malard. "Daratumumab Prevents Programmed Death Ligand‐1 Expression On Antigen‐presenting Cells in De Novo Multiple Myeloma." Cancer Med 2020.
MLA ZitierstilStocker, Nicolas, et al. "Daratumumab Prevents Programmed Death Ligand‐1 Expression On Antigen‐presenting Cells in De Novo Multiple Myeloma." Cancer Med 2020.
Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.